Download PDF
Horm Metab Res 2007; 39(11): 781-789
DOI: 10.1055/s-2007-992129
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

Human Aldehyde Oxidase 1 Interacts with ATP-binding Cassette Transporter-1 and Modulates its Activity in Hepatocytes

A. Sigruener 1 , C. Buechler 1 , E. Orsó 1 , A. Hartmann 2 , P. J. Wild 3 , L. Terracciano 4 , M. Roncalli 5 , S. R. Bornstein 6 , G. Schmitz 1
  • 1Institute of Clinical Chemistry and Laboratory Medicine, Regensburg University Medical Center, Regensburg, Germany
  • 2Institute of Pathology, Regensburg University Medical Center, Regensburg, Germany
  • 3Institute of Pathology, University Hospital Zürich, Zürich, Switzerland
  • 4Institute of Pathology, University Hospital, Basel, Switzerland
  • 5Department of Pathology, Humanitas Clinical Institute of Rozzano, University of Milan, Rozzano, Milano, Italy
  • 6Medical Clinic III, Medical Faculty Carl Gustav Carus, University of Technology, Dresden, Germany
Further Information

Publication History

received 15.05.2007

accepted 15.07.2007

Publication Date:
09 November 2007 (online)

Also available at
    Permissions and Reprints

Abstract

AOX1, a member of the cytosolic molybdenum hydroxylase family, has been identified by us earlier as an ABCA1-interacting protein. AOX1 is well-described as xenobiotic metabolizing enzyme, which upon oxidation of acetaldehyde and retinaldehyde to acetic acid and retinoic acid generates reactive oxygen species. Here we show that knock-down of AOX1 in HepG2 by small interfering RNA significantly reduced ABCA1-dependent lipid efflux and enhanced phagocytic uptake of microspheres similar to ABCA1 deficiency, without affecting ABCA1 mRNA and protein levels. ABCA1 and AOX1 are coexpressed in human hepatocytes, kidney proximal tubular epithelial cells, Leydig, and adrenocortical cells. Expression of ABCA1 and AOX1 was investigated by immunohistochemistry in liver tissue arrays. A strong AOX1 expression was found in normal liver, and in cirrhosis. In contrast, hepatocellular carcinomas showed either a complete loss or reduced expression of AOX1. Significant correlations were found between reduced AOX1 expression and tumor stage, or metastatic or regional lymph node states. Deregulation was also observed for ABCA1 expression but to a lesser extent. Our findings show that the interaction of ABCA1 with AOX1 modulates ABCA1-linked cellular functions such as lipid efflux and phagocytosis in hepatocytes, and the reduced expression of AOX1 in malignant transformed hepatocytes supports the differentiation dependent upregulation of AOX1.

Key words

AOX1 - ABCA1 - HepG2 - siRNA - efflux

References

  • 1 Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1.  J Biol Chem. 2000;  275 33053-33058
    CrossrefPubMedSearch in Google Scholar
  • 2 Bodzioch M, Orso E, Klucken J, Langmann T, Boettcher A, Diederich W, Drobnik W, Barlage S, Buechler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.  Nat Genet. 1999;  22 347-351
    CrossrefPubMedSearch in Google Scholar
  • 3 Munehira Y, Ohnishi T, Kawamoto S, Furuya A, Shitara K, Imamura M, Yokota T, Takeda S, Amachi T, Matsuo M, Kioka N, Ueda K. Alpha1-syntrophin modulates turnover of ABCA1.  J Biol Chem. 2004;  279 15091-15095
    CrossrefPubMedSearch in Google Scholar
  • 4 Okuhira K, Fitzgerald ML, Sarracino DA, Manning JJ, Bell SA, Goss JL, Freeman MW. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux.  J Biol Chem. 2005;  280 39653-39664
    CrossrefPubMedSearch in Google Scholar
  • 5 Buechler C, Boettcher A, Bared SM, Probst MC, Schmitz G. The carboxyterminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex.  Biochem Biophys Res Commun. 2002;  293 759-765
    CrossrefPubMedSearch in Google Scholar
  • 6 Buechler C, Bared SM, Aslanidis C, Ritter M, Drobnik W, Schmitz G. Molecular and functional interaction of the ATP-binding cassette transporter A1 with Fas-associated death domain protein.  J Biol Chem. 2002;  277 41307-41310
    CrossrefPubMedSearch in Google Scholar
  • 7 Nofer JR, Remaley AT, Feuerborn R, Wolinnska I, Engel T, Eckardstein A von, Assmann G. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.  J Lipid Res. 2006;  47 794-803
    PubMedSearch in Google Scholar
  • 8 Hirano K, Matsuura F, Tsukamoto K, Zhang Z, Matsuyama A, Takaishi K, Komuro R, Suehiro T, Yamashita S, Takai Y, Matsuzawa Y. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux.  FEBS Lett. 2000;  484 275-279
    CrossrefPubMedSearch in Google Scholar
  • 9 Nofer JR, Feuerborn R, Levkau B, Sokoll A, Seedorf U, Assmann G. Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux.  J Biol Chem. 2003;  278 53055-53062
    CrossrefPubMedSearch in Google Scholar
  • 10 Engel T, Lueken A, Bode G, Hobohm U, Lorkowski S, Schlueter B, Rust S, Cullen P, Pech M, Assmann G, Seedorf U. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export.  FEBS Lett. 2004;  566 241-246
    CrossrefPubMedSearch in Google Scholar
  • 11 Bared SM, Buechler C, Boettcher A, Dayoub R, Sigruener A, Grandl M, Rudolph C, Dada A, Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells.  Mol Biol Cell. 2004;  15 5399-5407
    CrossrefPubMedSearch in Google Scholar
  • 12 Garattini E, Mendel R, Romao MJ, Wright R, Terao M. Mammalian molybdo-flavoenzymes, an expanding family of proteins: structure, genetics, regulation, function and pathophysiology.  Biochem J. 2003;  372 15-32
    CrossrefPubMedSearch in Google Scholar
  • 13 Moriwaki Y, Yamamoto T, Takahashi S, Tsutsumi Z, Hada T. Widespread cellular distribution of aldehyde oxidase in human tissues found by immunohistochemistry staining.  Histol Histopathol. 2001;  16 745-753
    PubMedSearch in Google Scholar
  • 14 Obach RS. Potent inhibition of human liver aldehyde oxidase by raloxifene.  Drug Metab Dispos. 2004;  32 89-97
    CrossrefPubMedSearch in Google Scholar
  • 15 Obach RS, Huynh P, Allen MC, Beedham C. Human liver aldehyde oxidase: inhibition by 239 drugs.  J Clin Pharmacol. 2004;  44 7-19
    CrossrefPubMedSearch in Google Scholar
  • 16 Moriwaki Y, Yamamoto T, Higashino K. Distribution and pathophysiologic role of molybdenum-containing enzymes.  Histol Histopathol. 1997;  12 513-524
    PubMedSearch in Google Scholar
  • 17 Shaw S, Jayatilleke E. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat.  Biochem J. 1990;  268 579-583
    PubMedSearch in Google Scholar
  • 18 Wright RM, MacManaman JL, Repine JE. Alcohol-induced breast cancer: a proposed mechanism.  Free Radic Biol Med. 1999;  26 348-354
    CrossrefPubMedSearch in Google Scholar
  • 19 Tomita S, Tsujita M, Ichikawa Y. Retinal oxidase is identical to aldehyde oxidase.  FEBS Lett. 1993;  336 272-274
    CrossrefPubMedSearch in Google Scholar
  • 20 Huang DY, Ichikawa Y. Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol.  Biochem Biophys Res Commun. 1994;  205 1278-1283
    CrossrefPubMedSearch in Google Scholar
  • 21 Colakoglu N, Kukner A, Oner J, Sonmez MF, Oner H, Ozan E. Effects of high dose retinoic acid on TGF-beta2 expression during pancreatic organogenesis.  J Mol Histol. 2005;  36 413-418
    PubMedSearch in Google Scholar
  • 22 Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Lattimore S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA, Costello E, Neoptolemos J, Lemoine NR. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma.  Gastroenterology. 2005;  129 1454-1463
    CrossrefPubMedSearch in Google Scholar
  • 23 Vendrov AE, Madamanchi NR, Hakim ZS, Rojas M, Runge MS. Thrombin and NAD(P)H oxidase-mediated regulation of CD44 and BMP4-Id pathway in VSMC, restenosis, and atherosclerosis.  Circ Res. 2006;  98 1254-1263
    CrossrefPubMedSearch in Google Scholar
  • 24 Langmann T, Mauerer R, Zahn A, Moehle C, Probst M, Stremmel W, Schmitz G. Real-time reverse transcription-PCR expression profiling of the complete human ATP-binding cassette transporter superfamily in various tissues.  Clin Chem. 2003;  49 230-238
    CrossrefPubMedSearch in Google Scholar
  • 25 Drobnik W, Borsukova H, Boettcher A, Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains.  Traffic. 2002;  3 268-278
    CrossrefPubMedSearch in Google Scholar
  • 26 Dini L, Lentini A, Diez GD, Rocha M, Falasca L, Serafino L, Vidal-Vanaclocha F. Phagocytosis of apoptotic bodies by liver endothelial cells.  J Cell Sci. 1995;  108 ((Pt 3)) 967-973
    PubMedSearch in Google Scholar
  • 27 Zha X, Genest  Jr  J, MacPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport.  J Biol Chem. 2001;  276 39476-39483
    CrossrefPubMedSearch in Google Scholar
  • 28 Zha X, Gauthier A, Genest J, MacPherson R. Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1)-mediated cholesterol efflux.  J Biol Chem. 2003;  278 10002-10005
    CrossrefPubMedSearch in Google Scholar
  • 29 Bondy SC, Orozco J. Effects of ethanol treatment upon sources of reactive oxygen species in brain and liver.  Alcohol Alcohol. 1994;  29 375-383
    PubMedSearch in Google Scholar
  • 30 Shaw S, Jayatilleke E. The role of cellular oxidases and catalytic iron in the pathogenesis of ethanol-induced liver injury.  Life Sci. 1992;  50 2045-2052
    CrossrefPubMedSearch in Google Scholar
  • 31 Shaw S, Jayatilleke E. Cimetidine as a scavenger of ethanol-induced free radicals.  Alcohol. 1992;  9 363-367
    CrossrefPubMedSearch in Google Scholar
  • 32 Shaw S, Eng J, Jayatilleke E. Ethanol-induced free radical injury to the hepatocyte glucagon receptor.  Alcohol. 1995;  12 273-277
    CrossrefPubMedSearch in Google Scholar
  • 33 Wright RM, Riley MG, Weigel LK, Ginger LA, Costantino DA, MacManaman JL. Activation of the human aldehyde oxidase (hAOX1) promoter by tandem cooperative Sp1/Sp3 binding sites: identification of complex architecture in the hAOX upstream DNA that includes a proximal promoter, distal activation sites, and a silencer element.  DNA Cell Biol. 2000;  19 459-474
    CrossrefPubMedSearch in Google Scholar
  • 34 Mira L, Maia L, Barreira L, Manso CF. Evidence for free radical generation due to NADH oxidation by aldehyde oxidase during ethanol metabolism.  Arch Biochem Biophys. 1995;  318 53-58
    CrossrefPubMedSearch in Google Scholar
  • 35 Wright RM, Weigel LK, Repine JE. Aldehyde oxidase generates deoxyribonucleic acid single strand nicks in vitro.  Redox Rep. 1995;  1 313-321
    PubMedSearch in Google Scholar
  • 36 Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease.  Circ Res. 2000;  86 494-501
    CrossrefPubMedSearch in Google Scholar
  • 37 Babior BM. NADPH oxidase.  Curr Opin Immunol. 2004;  16 42-47
    CrossrefPubMedSearch in Google Scholar
  • 38 Wang Y, Zeigler MM, Lam GK, Hunter MG, Eubank TD, Khramtsov VV, Tridandapani SV, Sen CK, Marsh CB. The Role of the NADPH Oxidase Complex, p38 MAPK and Akt in Regulating Human Monocyte/Macrophage Survival.  Am J Respir Cell Mol Biol. 2007;  36 68-77
    PubMedSearch in Google Scholar
  • 39 Nagao S, Murao K, Imachi H, Cao WM, Yu X, Li J, Matsumoto K, Nishiuchi T, Ahmed RA, Wong NC, Ueda K, Ishida T. Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells.  FEBS Lett. 2006;  580 4371-4376
    CrossrefPubMedSearch in Google Scholar
  • 40 Landry YD, Denis M, Nandi S, Bell S, Vaughan AM, Zha X. ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions.  J Biol Chem. 2006;  281 36091-36101
    CrossrefPubMedSearch in Google Scholar
  • 41 Nofer JR, Giet M van der, Tolle M, Wolinska I, Wnuck LK von, Baba HA, Tietge UJ, Godecke A, Ishii I, Kleuser B, Schafers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S. 1P3.  J Clin Invest. 2004;  113 569-581
    CrossrefPubMedSearch in Google Scholar
  • 42 Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors.  BMJ. 1999;  319 1523-1528
    CrossrefPubMedSearch in Google Scholar
  • 43 Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study.  Lancet. 1977;  2 153-155
    PubMedSearch in Google Scholar
  • 44 Criqui MH, Cowan LD, Tyroler HA, Bangdiwala S, Heiss G, Wallace RB, Cohn R. Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: results form the Lipid Research Clinics Follow-up Study.  Am J Epidemiol. 1987;  126 629-637
    PubMedSearch in Google Scholar
  • 45 Beulens JW, Sierksma A, Tol A van, Fournier N, Gent T van, Paul JL, Hendriks HF. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1.  J Lipid Res. 2004;  45 1716-1723
    PubMedSearch in Google Scholar
  • 46 Wang XD. Alcohol, vitamin A, and cancer.  Alcohol. 2005;  35 251-258
    CrossrefPubMedSearch in Google Scholar
  • 47 Terao M, Kurosaki M, Barzago MM, Varasano E, Boldetti A, Bastone A, Fratelli M, Garattini E. Avian and canine aldehyde oxidases: novel insights into the biology and evolution of molybdo-flavoenzymes.  J Biol Chem. 2006;  281 19748-19761
    CrossrefPubMedSearch in Google Scholar
  • 48 Langmann T, Liebisch G, Moehle C, Schifferer R, Dayoub R, Heiduczek S, Grandl M, Dada A, Schmitz G. Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux.  Biochim Biophys Acta. 2005;  1740 155-161
    PubMedSearch in Google Scholar
  • 49 Beedham C, Miceli JJ, Obach RS. Ziprasidone metabolism, aldehyde oxidase, and clinical implications.  J Clin Psychopharmacol. 2003;  23 229-232
    CrossrefPubMedSearch in Google Scholar
  • 50 Brown RR, Estoup MW. Comparison of the metabolic effects observed in patients treated with ziprasidone versus olanzapine.  Int Clin Psychopharmacol. 2005;  20 105-112
    CrossrefPubMedSearch in Google Scholar
  • 51 Yang YM, Huang DY, Liu GF, Zhong JC, Du K, Li YF, Song XH. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on vitamin A metabolism in mice.  J Biochem Mol Toxicol. 2005;  19 327-335
    CrossrefPubMedSearch in Google Scholar
  • 52 Shaban Z, El-Shazly S, Abdelhady S, Fattouh I, Muzandu K, Ishizuka M, Kimura K, Kazusaka A, Fujita S. Down regulation of hepatic PPARalpha function by AhR ligand.  J Vet Med Sci. 2004;  66 1377-1386
    CrossrefPubMedSearch in Google Scholar
  • 53 Neumeier M, Weigert J, Schaffler A, Weiss TS, Schmidl C, Buttner R, Bollheimer C, Aslanidis C, Scholmerich J, Buechler C. Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro.  Biochem Biophys Res Commun. 2006;  350 731-735
    CrossrefPubMedSearch in Google Scholar
  • 54 Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.  Nat Med. 2001;  7 53-58
    PubMedSearch in Google Scholar
  • 55 Selva DM, Hirsch-Reinshagen V, Burgess B, Zhou S, Chan J, MacIsaac S, Hayden MR, Hammond GL, Vogl AW, Wellington CL. The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility.  J Lipid Res. 2004;  45 1040-1050
    PubMedSearch in Google Scholar

Correspondence

Prof.Dr.med. G. Schmitz

Institute of Clinical Chemistry

Regensburg University Medical Center

Franz-Josef-Strauss-Allee 11

93042 Regensburg

Germany

Phone: +49/941/944 62 01

Fax: +49/941/944 62 02

Email: gerd.schmitz@klinik.uni-regensburg.de